Education
About Us
Working with TipRanks
Follow Us
Rhythm Biosciences Ltd. (AU:RHY)
ASX:RHY
RHY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.14
Previous CloseN/A
Volume786.78K
Average Volume (3M)211.69K
Market Cap
AU$21.74M
Enterprise ValueAU$14.28M
Total Cash (Recent Filing)AU$6.43M
Total Debt (Recent Filing)AU$78.50K
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding289,846,740
10 Day Avg. Volume228,359
30 Day Avg. Volume211,686
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Rhythm Biosciences Ltd. News
PremiumCompany Announcements
Rhythm Biosciences Announces Quotation of New Securities
PremiumCompany Announcements
FIL Limited Increases Stake in Rhythm BiosciencesPremiumCompany Announcements
Rhythm Biosciences Secures Shareholder Support at EGM
PremiumCompany Announcements
Rhythm Biosciences Reports First Commercial Sales of geneType™ Products
PremiumCompany Announcements
Rhythm Biosciences Issues Unquoted Securities to Employees
PremiumCompany Announcements
Rhythm Biosciences Appoints New CFO Amid Global Growth PlansPremiumCompany Announcements
Rhythm Biosciences Announces Cessation of Employee Securities---
Options Prices
Currently, No data available
---
Ownership Overview
14.24% Insiders
―
Mutual Funds
― Other Institutional Investors
85.76% Public Companies and
Individual Investors
RHY FAQ
What was Rhythm Biosciences Ltd.’s price range in the past 12 months?
Rhythm Biosciences Ltd. lowest share price was AU$0.04 and its highest was AU$0.14 in the past 12 months.
What is Rhythm Biosciences Ltd.’s market cap?
Rhythm Biosciences Ltd.’s market cap is AU$21.74M.
When is Rhythm Biosciences Ltd.’s upcoming earnings report date?
Rhythm Biosciences Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 137 days.
How were Rhythm Biosciences Ltd.’s earnings last quarter?
Rhythm Biosciences Ltd. released its earnings results on Feb 20, 2025. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.002.
Is Rhythm Biosciences Ltd. overvalued?
According to Wall Street analysts Rhythm Biosciences Ltd.’s price is currently Overvalued.
Does Rhythm Biosciences Ltd. pay dividends?
Rhythm Biosciences Ltd. does not currently pay dividends.
What is Rhythm Biosciences Ltd.’s EPS estimate?
Rhythm Biosciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rhythm Biosciences Ltd. have?
Rhythm Biosciences Ltd. has 289,846,740 shares outstanding.
What happened to Rhythm Biosciences Ltd.’s price movement after its last earnings report?
Rhythm Biosciences Ltd. reported an EPS of AU$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Rhythm Biosciences Ltd.?
Currently, no hedge funds are holding shares in AU:RHY
---
Rhythm Biosciences Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
AU:RHY Sentiment 55%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.05%
12-Months-Change
Fundamentals
Return on Equity
-71.10%
Trailing 12-Months
Asset Growth
205.13%
Trailing 12-Months
Company Description
Rhythm Biosciences Ltd.
Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
---
Technical Analysis
Cochlear Limited
―
CSL
―
Fisher & Paykel Healthcare Corporation Limited
―
Nanosonics Limited
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
---